![]() Its portfolio is comprised primarily of investments in leveraged loans issued by middle market companies. Its investments generally provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its investments. It primarily invests in senior and unitranche-leveraged loans and mezzanine debt and, to a lesser extent, equity issued by private United States middle-market companies. The Company provides customized financing solutions to United States middle-market businesses. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.Ĭompany Description: Saratoga Investment Corp. The rating according to our strategy based on John Neff changed from 40% to 79% based on the firm’s underlying fundamentals and the stock’s valuation. SARATOGA INVESTMENT CORP ( SAR) is a small-cap value stock in the Investment Services industry. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.ĭetailed Analysis of SEMLER SCIENTIFIC INC The following table summarizes whether the stock meets each of this strategy's tests. Its customers for QuantaFlo include insurance plans, physician groups, and others. It has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of glucose levels in insulin-dependent patients with Type 2 diabetes. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. QuantaFlo is a four-minute in-office blood flow test. ![]() Its cardiac and vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). The Company develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. ![]() provides technology solutions to healthcare providers. Company Description: Semler Scientific, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |